EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The transplant site as an immunological intervention in pancreatic islet transplantation

Midhat H. Abdulreda, Per-Olof Berggren

Cell Transplantation · 2026-10 · 35

DOI: 10.1177/09636897261508943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Transplantation, online erschienen am 17.11.2026. Verfasst von Midhat H. Abdulreda und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Division of Microbiology and Infectious Diseases, National Eye Institute, Diabetes Research Institute Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic islet transplantation has traditionally relied on systemic immunosuppression to control graft rejection. However, this strategy remains constrained by drug toxicity, incomplete graft protection, and recurrent immune injury. Recent advances in stem cell-derived islets and graft engineering have expanded the therapeutic landscape, but they do not eliminate the need for a supportive biological environment. We therefore propose that the anatomical transplant site should be considered an active immunological and physiological determinant of graft outcome, rather than a passive surgical location. The anterior chamber of the eye (ACE) illustrates this site-directed approach. Its naturally immune-privileged, vascularized, transparent, and accessible microenvironment supports islet engraftment, enables longitudinal monitoring, and reduces exposure to inflammatory injury. Preclinical and early translational findings further show that intraocular islet grafts survive long term when paired with transient immune modulation and promote donor-specific immune regulation beyond the local graft site. Similar outcomes may be achievable in engineered transplant sites designed to provide comparable biological support together with limited, targeted immune therapy. Future advances in islet transplantation may therefore depend not only on improved drugs and engineered grafts, but also on selecting or designing transplant sites that actively promote graft survival, immune regulation, and durable graft acceptance.

Förderung

  • Division of Microbiology and Infectious Diseases
  • National Eye Institute
  • Diabetes Research Institute Foundation

Zitieren

APA

Abdulreda, M. H., & Berggren, P. (2026). The transplant site as an immunological intervention in pancreatic islet transplantation. Cell Transplantation, 35. https://doi.org/10.1177/09636897261508943

Vancouver

Abdulreda MH, Berggren P. The transplant site as an immunological intervention in pancreatic islet transplantation. Cell Transplantation. 2026;35. doi:10.1177/09636897261508943

BibTeX
@article{Abdulreda2026,
  author = {Abdulreda, Midhat H. and Berggren, Per-Olof},
  title = {The transplant site as an immunological intervention in pancreatic islet transplantation},
  journal = {Cell Transplantation},
  year = {2026},
  volume = {35},
  doi = {10.1177/09636897261508943}
}
Kostenlos starten →